Related Experiment Video
Updated: Jul 28, 2025

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
[Correlation between 25-hydroxyvitamin D and nephroblastoma in children and its value in assessing disease prognosis]
1Department of Pediatrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
Insights
Children with nephroblastoma have lower 25-hydroxyvitamin D [25-(OH)D] levels, which are linked to poorer outcomes. This vitamin D metabolite shows potential for predicting the prognosis of pediatric nephroblastoma.
Area of Science:
- Pediatric Oncology
- Endocrinology
- Biochemistry
Context:
- Nephroblastoma, a common pediatric kidney cancer, presents diagnostic and prognostic challenges.
- Vitamin D deficiency is increasingly recognized as a factor in various diseases, including cancers.
Purpose:
- To investigate the association between 25-hydroxyvitamin D [25-(OH)D] levels and the prognosis of nephroblastoma in children.
- To evaluate the utility of 25-(OH)D as a predictive biomarker for pediatric nephroblastoma outcomes.
Summary:
- Children with nephroblastoma exhibited significantly lower serum creatinine and 25-(OH)D levels compared to healthy controls.
- Poor prognosis in nephroblastoma was associated with larger tumor size, advanced stage, metastasis, and lower 25-(OH)D levels.
- Serum 25-(OH)D levels demonstrated a significant negative correlation with therapeutic response and were identified as a risk factor for poor prognosis.
Impact:
- Findings suggest that 25-(OH)D levels can serve as a valuable tool for predicting nephroblastoma prognosis in children.
- This research highlights the potential role of vitamin D status in pediatric cancer outcomes and warrants further investigation.
Objectives:
To study the correlation between 25-hydroxyvitamin D [25-(OH)D] and nephroblastoma in children and its value in assessing the prognosis of the disease.
Methods:
A total of 50 children with nephroblastoma who were admitted from January 2018 to December 2022 were included as the nephroblastoma group, and according to the postoperative pathological type, they were divided into a good prognosis group with 38 children and a poor prognosis group with 12 children. A total of 50 healthy children who underwent physical examination during the same period of time served as the healthy control group. The above groups were compared in terms of serum creatinine and 25-(OH)D level. A Spearman correlation analysis was used to investigate the correlation between serum 25-(OH)D level and therapeutic effect reaction. A multivariate logistic regression analysis was used to identify the risk factors affecting the prognosis of nephroblastoma in children.
Results:
The nephroblastoma group had significantly lower levels of serum creatinine and 25-(OH)D than the healthy control group (P<0.05). Compared with the good prognosis group, the poor prognosis group had a significantly larger tumor diameter, a significantly higher proportion of children with stage III-IV tumors, a significantly higher rate of tumor metastasis, and significantly lower serum levels of creatinine and 25-(OH)D (P<0.05). The Spearman correlation analysis showed that serum 25-(OH)D level was negatively correlated with therapeutic effect reaction (rs=-0.685, P<0.001). The multivariate logistic regression analysis showed that tumor diameter ≥10 cm, stage III-IV tumors, presence of tumor metastasis, and 25-(OH)D <19 ng/mL were closely associated with the poor prognosis of nephroblastoma in children (P<0.05). Serum 25-(OH)D level had an area under the curve of 0.805 (95%CI: 0.706-0.903, P<0.001) in evaluating the prognosis of nephroblastoma in children, with a Youden index of 0.512, a sensitivity of 0.938, and a specificity of 0.575 at the optimal cut-off value of 1.764 ng/mL.
Conclusions:
There is a significant correlation between 25-(OH)D level and the prognosis of nephroblastoma in children, and 25-(OH)D can be used for prognosis prediction.
More Related Videos
05:56Demonstrating a Linear Relationship Between Vascular Endothelial Growth Factor and Luteinizing Hormone in Kidney Cortex Extracts
Published on: January 22, 2020
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Serum Studies: Renal Function Tests
Chronic Kidney Disease II: Clinical Manifestations
Cancer Survival Analysis
Chronic Kidney Disease III: Interprofessional Care